Brain Injury Devices in Focus During Fort Liberty Soldier Touchpoint

U.S. Army Lt. Col. Wendra Galfand, the Director of Medical Education and Research at Womack Army Medical Center, operates an intercranial hemorrhage assessment device during a soldier touchpoint event, Fort Liberty, N.C., Sept. 18, 2024. During the touchpoint, advanced developers with the U.S. Army Medical Materiel Development Activity and the North Carolina Center for Optimizing Military Performance gathered performance feedback from soldiers employing two brain trauma assessment devices currently under development at USAMMDA. USAMMDA develops, delivers, and fields critical drugs, vaccines, biologics, devices, and medical support equipment to protect and preserve the lives of Warfighters across the globe. USAMMDA project managers guide the development of medical products for the U.S. Army Medical Department, other U.S. military services, the Joint Staff, the Defense Health Agency, and the U.S. Special Operations community. The process takes promising technology from the Defense Department, industry, and academia to U.S. forces, from the testing required for U.S. Food and Drug Administration approval or licensing to fielding and sustainment of the finished product (photo credit: U.S. Army photo by Cameron Parks).